You are here

Company Monitoring Page for Merck

latest headlines for company on cafepharma

3 Things You Absolutely Must Know About Merck

Motley Fool

Tue, 01/12/16 - 02:30 pm

Tags:

Merck, M&A, Keytruda, elbasvir/grazoprevir, Kenneth Frazier

Analyzing Keytruda: Why Is It Important for Merck?

Yahoo/Market Realist

Mon, 01/11/16 - 06:35 pm

Tags:

Keytruda, Merck

Merck’s 4Q15 Earnings: Expected Growth Contributors

Yahoo/Market Realist

Fri, 01/8/16 - 09:50 am

Tags:

Merck, earnings

3 Potential Blockbuster Drugs Launching in 2016

Investors.com

Wed, 01/6/16 - 10:57 am

Tags:

Merck, hepatitis C, elbasvir/grazoprevir, Gilead Sciences, sofosbuvir/velpatasvir, Eli Lilly, psoriasis, ixekizumab

Merck CEO: Eager for deals, strong prospects for new drugs

Yahoo/AP

Tue, 01/5/16 - 03:14 pm

Tags:

Merck, Kenneth Frazier, Pharma CEOs

Is AstraZeneca a Better Suitor for Relypsa Than Sanofi?

Bidness, ETC

Mon, 12/28/15 - 10:03 am

Tags:

AstraZeneca, Relypsa, Sanofi, Merck, M&A

This Is the Most Effective Way to Treat Lung Cancer, Study Shows

Motley Fool

Mon, 12/28/15 - 09:49 am

Tags:

lung cancer, Galena Biopharma, Inovio, Merck, Bristol-Myers Squibb

10 Big Idea Biotech Startups From 2015

Forbes

Sat, 12/26/15 - 10:58 am

Tags:

biotech, Merck, Moderna Therapeutics, GSK, Spero, Biogen, Neon Therapeutics, RaNA

The Best Merck & Co. Inc. Headlines in 2015

Motley Fool

Thu, 12/24/15 - 10:18 am

Tags:

Merck, Keytruda, Jimmy Carter, hepatitis C, grazoprevir/elbagavir

Relypsa Gets More Attractive For Merck, Sanofi

Bidness, ETC

Wed, 12/23/15 - 09:26 pm

Tags:

Relypsa, Merck, Sanofi, M&A

Is Merck & Co. About to Derail Gilead Sciences?

Motley Fool

Tue, 12/22/15 - 09:59 pm

Tags:

Merck, Gilead Sciences, grazoprevir/elbasvir, Viekira Pak, AbbVie

Merck CEO: Using Keytruda Could Extend Patient's Life By 13 Months On Average

Yahoo/Benzinga

Tue, 12/22/15 - 10:37 am

Tags:

Merck, Kenneth Frazier, Keytruda, lung cancer

Can Merck Keytruda Crawl Back Above Bristol-Myers Opdivo?

Bidness, ETC

Sat, 12/19/15 - 11:36 am

Tags:

Merck, Keytruda, Bristol-Myers Squibb, Opdivo

Merck’s Share Price Has Been Volatile on Impending Drug Approvals

Yahoo/Market Realist

Fri, 12/18/15 - 12:31 pm

Tags:

Merck, elbasvir/grazoprevir, hepatitis C

Merck Will Soon See a Decision on Its New Hepatitis C Therapy

Yahoo/Market Realist

Thu, 12/17/15 - 01:52 pm

Tags:

Merck, hepatitis C, grazoprevir/elbasvir

10 Big Idea Biotech Startups From 2015

Forbes

Thu, 12/17/15 - 09:47 am

Tags:

biotech, Merck, GSK, Neon Therapeutics, Biogen, RaNA

Merck finally adds postsurgery med Bridion to its U.S. lineup. Will hospital buyers step up?

Fierce Pharma Marketing

Wed, 12/16/15 - 07:57 pm

Tags:

Merck's Vytorin Study Epitomizes Inherent Risks Of Major Clinical Trials

Forbes

Wed, 12/16/15 - 11:26 am

Tags:

Merck, Vytorin, clinical trials

FDA approves Merck drug to reverse effects of muscle relaxants

Yahoo/Reuters

Tue, 12/15/15 - 04:37 pm

Tags:

FDA, Merck, Bridion, sugammadex

Merck fails to win FDA panel backing for Vytorin heart claim

Yahoo/Reuters

Mon, 12/14/15 - 10:19 pm

Tags:

Merck, Vytorin, FDA, advisory panels

Pages

last 30 twitter posts